Systematic Review of Membrane Components of Gram-Positive Bacteria Responsible as Pyrogens for Inducing Human Monocyte/Macrophage Cytokine Release
暂无分享,去创建一个
[1] D. Savage,et al. Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium , 1986, Applied and environmental microbiology.
[2] K. Knox,et al. Characterization of group N streptococcus lipoteichoic acid , 1975, Infection and immunity.
[3] K. Knox,et al. Serological Studies on the Teichoic Acids of Lactobacillus plantarum , 1972, Infection and immunity.
[4] J. Baddiley,et al. Extraction and purification of lipoteichoic acids from Gram-positive bacteria. , 1975, Carbohydrate research.
[5] T. Lehner,et al. Immunisation of rhesus monkeys with Streptococcus mutans, Lactobacillus acidophilus and lipoteichoic acid for protection against dental caries. , 1982, Journal of medical microbiology.
[6] J. Abrams,et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. , 1992, Journal of immunology.
[7] R. Arakaki,et al. A lipoteichoic acid fraction of Enterococcus hirae activates cultured human monocytic cells via a CD14-independent pathway to promote cytokine production, and the activity is inhibited by serum components. , 1998, FEMS immunology and medical microbiology.
[8] T. Hartung,et al. Macroamphiphilic Components of Thermophilic Actinomycetes: Identification of Lipoteichoic Acid in Thermobifida fusca , 2008, Journal of bacteriology.
[9] T. Hartung,et al. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. , 2001 .
[10] C. Lowenstein,et al. Pathogen Recognition by Toll-like Receptor 2 Activates Weibel-Palade Body Exocytosis in Human Aortic Endothelial Cells* , 2007, Journal of Biological Chemistry.
[11] A. Halpern,et al. The Sorcerer II Global Ocean Sampling Expedition: Northwest Atlantic through Eastern Tropical Pacific , 2007, PLoS biology.
[12] William Wiley Navarre,et al. Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope , 1999, Microbiology and Molecular Biology Reviews.
[13] I. Azuma,et al. Structural studies on lipoteichoic acids from four Listeria strains , 1986, Journal of bacteriology.
[14] W. Fischer,et al. Separation of the poly(glycerophosphate) lipoteichoic acids of Enterococcus faecalis Kiel 27738, Enterococcus hirae ATCC 9790 and Leuconostoc mesenteroides DSM 20343 into molecular species by affinity chromatography on concanavalin A. , 1991, European journal of biochemistry.
[15] A. Tomasz,et al. Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid. , 1973, The Journal of biological chemistry.
[16] D. Jelley-Gibbs,et al. Lipoteichoic Acid Inhibits Interleukin-2 (IL-2) Function by Direct Binding to IL-2 , 2001, Clinical Diagnostic Laboratory Immunology.
[17] T. Hartung,et al. Comment on “Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus” , 2006, The Journal of Immunology.
[18] F. Re,et al. Commercial peptidoglycan preparations are contaminated with superantigen‐like activity that stimulates IL‐17 production , 2008, Journal of leukocyte biology.
[19] T. Hartung,et al. Comparison of Lipoteichoic Acid from Different Serotypes of Streptococcus pneumoniae* , 2006, Journal of Biological Chemistry.
[20] T. Hartung,et al. Cytokine induction by Gram-positive bacteria. , 2008, Immunobiology.
[21] O. Holst,et al. Opsonic Antibodies to Enterococcus faecalis Strain 12030 Are Directed against Lipoteichoic Acid , 2006, Infection and Immunity.
[22] J. Verhoef,et al. Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis. , 1993, Journal of medical microbiology.
[23] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[24] G. Shockman,et al. Cellular localization of lipoteichoic acid in Streptococcus faecalis , 1975, Journal of bacteriology.
[25] J. Metcalf,et al. Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase Pathway , 2008, PloS one.
[26] L. Kremer,et al. Mycobacterium tuberculosis Lipomannan Induces Apoptosis and Interleukin-12 Production in Macrophages , 2004, Infection and Immunity.
[27] S. Foster,et al. Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model , 2000, Infection and Immunity.
[28] S. Kusumoto,et al. Cytokine-inducing glycolipids in the lipoteichoic acid fraction from Enterococcus hirae ATCC 9790. , 1995, FEMS immunology and medical microbiology.
[29] J. Bertin,et al. Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan , 2003, Science.
[30] L. P. Sousa,et al. Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1. , 2008, The Journal of Immunology.
[31] D. Stechschulte,et al. Histamine induces Toll‐like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram‐positive and Gram‐negative bacterial cell wall components , 2004, Immunology.
[32] R. Schumann,et al. Immune responses induced by spirochetal outer membrane lipoproteins and glycolipids. , 2008, Immunobiology.
[33] U. Göbel,et al. Lipoteichoic Acid (LTA) of Streptococcus pneumoniaeand Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved* , 2003, The Journal of Biological Chemistry.
[34] Sun-Hee Kim,et al. Isolation and structural analysis of bamylocin A, novel lipopeptide from Bacillus amyloliquefaciens LP03 having antagonistic and crude oil-emulsifying activity , 2007, Archives of Microbiology.
[35] T. Hartung,et al. Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators1 , 2001, The Journal of Immunology.
[36] M. Dehouck,et al. Highly purified lipoteichoic acid from gram-positive bacteria induces in vitro blood–brain barrier disruption through glia activation: Role of pro-inflammatory cytokines and nitric oxide , 2006, Neuroscience.
[37] J. Bonmatin,et al. Lichenysins G, a novel family of lipopeptide biosurfactants from Bacillus licheniformis IM 1307: production, isolation and structural evaluation by NMR and mass spectrometry. , 1999, The Journal of antibiotics.
[38] Sarah K. Meadows,et al. TLRs Mediate IFN-γ Production by Human Uterine NK Cells in Endometrium1 , 2006, The Journal of Immunology.
[39] Ping-Chang Yang,et al. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: The role of TLR2 and NOD2 , 2007, Immunology and cell biology.
[40] K. Brandenburg,et al. Innate recognition of bacteria: engagement of multiple receptors. , 2002, Critical reviews in immunology.
[41] Bozhong Mu,et al. Isolation and characterization of a C12‐lipopeptide produced by Bacillus subtilis HSO 121 , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[42] W. Fischer,et al. Isomalto-oligosaccharide-containing lipoteichoic acid of Streptococcus sanguis. Microheterogeneity and distribution of chain substituents. , 1993, European journal of biochemistry.
[43] T. Beveridge. Structures of Gram-Negative Cell Walls and Their Derived Membrane Vesicles , 1999, Journal of bacteriology.
[44] S. M. Sullivan,et al. Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis , 2009, BMC Microbiology.
[45] V. Dennis,et al. Autocrine and Exocrine Regulation of Interleukin-10 Production in THP-1 Cells Stimulated with Borrelia burgdorferi Lipoproteins , 2002, Infection and Immunity.
[46] Sang Su Woo,et al. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines , 2007, Journal of leukocyte biology.
[47] F. Fiedler,et al. Occurrence and structure of lipoteichoic acids in the genus Staphylococcus , 1990, Archives of Microbiology.
[48] Thomas Hartung,et al. Cell Activation of Human Macrophages by Lipoteichoic Acid Is Strongly Attenuated by Lipopolysaccharide-binding Protein* , 2006, Journal of Biological Chemistry.
[49] R. Balakrishna,et al. Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells. , 2008, Immunology letters.
[50] W. Fischer. Molecular analysis of lipid macroamphiphiles by hydrophobic interaction chromatography, exemplified with lipoteichoic acids. , 1993, Analytical biochemistry.
[51] T. F. Murray,et al. The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan* , 2002, The Journal of Biological Chemistry.
[52] S. D. Hogg,et al. Competitive binding of calcium and magnesium to streptococcal lipoteichoic acid. , 1995, Biochimica et biophysica acta.
[53] Thomas Hartung,et al. Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase1 , 2002, The Journal of Immunology.
[54] I. Sutcliffe,et al. Atypical lipoteichoic acids of gram-positive bacteria , 1991, Journal of bacteriology.
[55] E. Latz,et al. Lipopolysaccharide-binding protein. , 2000, Chemical immunology.
[56] P. Janmey,et al. Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components1 , 2008, The Journal of Immunology.
[57] T. Alatossava,et al. Characterization of Lipoteichoic Acids as Lactobacillus delbrueckii Phage Receptor Components , 2004, Journal of bacteriology.
[58] H. O. D. op den Camp,et al. Structure of the lipoteichoic acids from Bifidobacterium bifidum spp. pennsylvanicum. , 1984, Biochimica et biophysica acta.
[59] E. Bröcker,et al. Production of IL-12 and IL-18 in human dendritic cells upon infection by Listeria monocytogenes. , 2003, FEMS immunology and medical microbiology.
[60] T. Hartung,et al. Synthetic Lipoteichoic Acid from Staphylococcus aureus Is a Potent Stimulus of Cytokine Release , 2002, The Journal of experimental medicine.
[61] K. Cox,et al. Lipoteichoic Acid Synergizes with Glycosphingolipids To Potently Stimulate Secretion of Interleukin-6 from Human Blood Cells , 2008, Clinical and Vaccine Immunology.
[62] S. Echigo,et al. A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells , 2008, Innate immunity.
[63] T. Hartung,et al. Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity. , 2011, Immunobiology.
[64] B. Andersson,et al. Gram-positive and Gram-negative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. , 2005, Cytokine.
[65] H. Redmond,et al. Induction of Bacterial Lipoprotein Tolerance Is Associated with Suppression of Toll-like Receptor 2 Expression* , 2002, The Journal of Biological Chemistry.
[66] W. Vollmer,et al. The Architecture of the Murein (Peptidoglycan) in Gram-Negative Bacteria: Vertical Scaffold or Horizontal Layer(s)? , 2004, Journal of bacteriology.
[67] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[68] S. Cummings,et al. Phenotypic variation in Streptomyces sp. DSM 40537, a lipoteichoic acid producing actinomycete , 2009, Letters in applied microbiology.
[69] E. Ito,et al. Comparative studies of lipoteichoic acids from several Bacillus strains , 1986, Journal of bacteriology.
[70] F. Fiedler,et al. Alanine ester-containing native lipoteichoic acids do not act as lipoteichoic acid carrier. Isolation, structural and functional characterization. , 1980, The Journal of biological chemistry.
[71] F. Sakai,et al. WS1279, a novel lipopeptide isolated from Streptomyces willmorei. Biological activities. , 1993, The Journal of antibiotics.
[72] A. Archibald,et al. Lipoteichoic acid and lipoteichoic acid carrier in Staphylococcus aureus H , 1975, FEBS letters.
[73] T. Hartung,et al. Use of Synthetic Derivatives To Determine the Minimal Active Structure of Cytokine-Inducing Lipoteichoic Acid , 2007, Clinical and Vaccine Immunology.
[74] Sebastian Hoffmann,et al. International validation of novel pyrogen tests based on human monocytoid cells. , 2005, Journal of immunological methods.
[75] Yimou Wu,et al. Mycoplasma genitalium Lipoproteins Induce Human Monocytic Cell Expression of Proinflammatory Cytokines and Apoptosis by Activating Nuclear Factor κB , 2008, Mediators of inflammation.
[76] T. Theodore,et al. Lipoteichoic Acid Localization in Mesosomal Vesicles of Staphylococcus aureus , 1974, Journal of bacteriology.
[77] G. Jung,et al. Physicochemical and biological analysis of synthetic bacterial lipopeptides : Validity of the concept of ’ endotoxic conformation ’ 1 , 2003 .
[78] K. Knox,et al. Comparative Studies on the Isolation of Membrane Lipoteichoic Acid from Lactobacillus fermenti , 1973, Journal of bacteriology.
[79] J. Mcghee,et al. Chemical properties and immunobiological activities of streptococcal lipoteichoic acids. , 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.
[80] L. L. Jackson,et al. Lipoteichoic acid from Listeria monocytogenes , 1983, Journal of bacteriology.
[81] T. Hartung,et al. Internalization and Coreceptor Expression Are Critical for TLR2-Mediated Recognition of Lipoteichoic Acid in Human Peripheral Blood , 2010, The Journal of Immunology.
[82] M. Housaindokht,et al. Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633. , 2005, Journal of microbiology.
[83] K. Fukase,et al. Meso-Diaminopimelic Acid and Meso-Lanthionine, Amino Acids Specific to Bacterial Peptidoglycans, Activate Human Epithelial Cells through NOD11 , 2006, The Journal of Immunology.
[84] L. Ingram,et al. Purification of lipoteichoic acids by using phosphatidyl choline vesicles , 1978, Infection and immunity.
[85] Mardas Daneshian,et al. Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. , 2009, ALTEX.
[86] Sebastian Hoffmann,et al. International validation of pyrogen tests based on cryopreserved human primary blood cells. , 2006, Journal of immunological methods.
[87] B. Lindberg,et al. Structural studies of a teichoic acid from Streptococcus agalactiae type III. , 1986, Carbohydrate research.
[88] P. Owen,et al. Isolation and characterization of a mannan from mesosomal membrane vesicles of Micrococcus lysodeikticus. , 1975, Biochimica et biophysica acta.
[89] S. Han,et al. Monoacyl Lipoteichoic Acid from Pneumococci Stimulates Human Cells but Not Mouse Cells , 2005, Infection and Immunity.
[90] T. Hartung,et al. Structural Decomposition and Heterogeneity of Commercial Lipoteichoic Acid Preparations , 2002, Infection and Immunity.
[91] J. Beuth,et al. Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid , 2004, Medical Microbiology and Immunology.
[92] D. Philpott,et al. Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition , 2004, EMBO reports.
[93] X. You,et al. [Mycoplasma genitalium lipid-associated membrane proteins induce human monocytic cell express proinflammatory cytokines and apoptosis by activating nuclear factor kappaB]. , 2007, Wei sheng wu xue bao = Acta microbiologica Sinica.
[94] K. Fukase,et al. Muramyldipeptide and diaminopimelic acid‐containing desmuramylpeptides in combination with chemically synthesized Toll‐like receptor agonists synergistically induced production of interleukin‐8 in a NOD2‐ and NOD1‐dependent manner, respectively, in human monocytic cells in culture , 2004, Cellular microbiology.
[95] T. Hartung,et al. Definition of Structural Prerequisites for Lipoteichoic Acid-Inducible Cytokine Induction by Synthetic Derivatives1 , 2003, The Journal of Immunology.
[96] W. Fischer,et al. Hydrophobic interaction chromatography fractionates lipoteichoic acid according to the size of the hydrophilic chain: a comparative study with anion-exchange and affinity chromatography for suitability in species analysis. , 1992, Analytical biochemistry.
[97] Thomas Hartung,et al. Cytokine induction by purified lipoteichoic acids from various bacterial species – Role of LBP, sCD14, CD14 and failure to induce IL‐12 and subsequent IFN‐γ release , 2002, European journal of immunology.
[98] W. Fischer. 'Lipoteichoic acid' of Bifidobacterium bifidum subspecies pennsylvanicum DSM 20239. A lipoglycan with monoglycerophosphate side chains. , 1987, European journal of biochemistry.
[99] G. Teti,et al. Mediation of Staphylococcus saprophyticus adherence to uroepithelial cells by lipoteichoic acid , 1987, Infection and immunity.
[100] S. Sugawara,et al. Priming of human oral epithelial cells by interferon-gamma to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans. , 2002, Journal of medical microbiology.
[101] W. Fischer,et al. Improved preparation of lipoteichoic acids. , 1983, European journal of biochemistry.
[102] T. Hartung,et al. MDP and other muropeptides--direct and synergistic effects on the immune system. , 2006, Journal of endotoxin research.
[103] T. Hartung,et al. Lipoteichoic acid from Lactobacillus plantarum elicits both the production of interleukin-23p19 and suppression of pathogen-mediated interleukin-10 in THP-1 cells. , 2007, FEMS immunology and medical microbiology.
[104] D. Chung,et al. Lipoteichoic Acid Isolated from Lactobacillus plantarum Inhibits Lipopolysaccharide-Induced TNF-α Production in THP-1 Cells and Endotoxin Shock in Mice1 , 2008, The Journal of Immunology.
[105] M. Okuhara,et al. WS1279, a novel lipopeptide isolated from Streptomyces willmorei. Fermentation, isolation and physico-chemical properties. , 1993, The Journal of antibiotics.
[106] R. Nau,et al. Enzyme Immunoassay Detecting Teichoic and Lipoteichoic Acids versus Cerebrospinal Fluid Culture and Latex Agglutination for Diagnosis of Streptococcus pneumoniae Meningitis , 1998, Journal of Clinical Microbiology.
[107] W. Fischer,et al. Distribution analyses of chain substituents of lipoteichoic acids by chemical degradation. , 1989, European journal of biochemistry.
[108] Thomas Hartung,et al. An in vitro pyrogen safety test for immune-stimulating components on surfaces. , 2007, Biomaterials.
[109] J. Peter-Katalinic,et al. The structure of pneumococcal lipoteichoic acid. Improved preparation, chemical and mass spectrometric studies. , 1992, European journal of biochemistry.
[110] J. H. Pollack,et al. D-alanyl-lipoteichoic acid in Lactobacillus casei: secretion of vesicles in response to benzylpenicillin. , 1992, Journal of general microbiology.
[111] W. Fischer,et al. Trihexosyldiacylglycerol and Acyltrihexosyldiacylglycerol as Lipid Anchors of the Lipoteichoic Acid of Lactobacillus casei DSM 20021 , 1978, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[112] W. Fischer,et al. Small and medium-angle X-ray analysis of bacterial lipoteichoic acid phase structure. , 1991, European journal of biochemistry.
[113] D. Morrison,et al. Commercial Preparations of Lipoteichoic Acid Contain Endotoxin That Contributes to Activation of Mouse Macrophages In Vitro , 2001, Infection and Immunity.
[114] J. Dengjel,et al. Staphylococcus aureus Deficient in Lipidation of Prelipoproteins Is Attenuated in Growth and Immune Activation , 2005, Infection and Immunity.
[115] W. Fischer,et al. Isomalto-oligosaccharide-containing lipoteichoic acid of Streptococcus sanguis. Basic structure. , 1993, European journal of biochemistry.
[116] T. Evans,et al. Butanol-extracted lipoteichoic acid induces in vivo leukocyte adhesion. , 2007, Biochemical and biophysical research communications.
[117] B. Beutler. TLRs and innate immunity. , 2009, Blood.
[118] G. Jung,et al. Lipopeptide structure determines TLR2 dependent cell activation level , 2005, The FEBS journal.
[119] J. Maurer,et al. Molecular analysis of lipoteichoic acid from Streptococcus agalactiae , 1991, Journal of bacteriology.
[120] J. Wain,et al. Effect of Deletion or Overexpression of the 19-Kilodalton Lipoprotein Rv3763 on the Innate Response to Mycobacterium tuberculosis , 2005, Infection and Immunity.
[121] J. M. ten Cate,et al. Lipoteichoic Acid Inhibits Remineralization of Artificial Subsurface Lesions and Surface-softened Enamel , 1995, Journal of dental research.
[122] T. Nealon,et al. Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease , 1983, Infection and immunity.
[123] N. McElvaney,et al. TLR-Induced Inflammation in Cystic Fibrosis and Non-Cystic Fibrosis Airway Epithelial Cells1 , 2005, The Journal of Immunology.
[124] S. D. De Keersmaecker,et al. Functional Analysis of d-Alanylation of Lipoteichoic Acid in the Probiotic Strain Lactobacillus rhamnosus GG , 2007, Applied and Environmental Microbiology.
[125] Isolation and partial characterisation of the Triton X-100 solubilised protein antigen from Mycobacterium tuberculosis. , 1999, Journal of medical microbiology.
[126] CHEMICAL FACTORS IN THE CONTROL OF THE CIRCULATION , 1929, British medical journal.
[127] S. V. van Deventer,et al. Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid , 2003, Infection and Immunity.
[128] Osamu Takeuchi,et al. Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus1 , 2005, The Journal of Immunology.
[129] V. Dennis,et al. Interleukin-10 Modulates Proinflammatory Cytokines in the Human Monocytic Cell Line THP-1 Stimulated withBorrelia burgdorferi Lipoproteins , 2000, Infection and Immunity.
[130] W. Fischer,et al. On the basic structure of poly(glycerophosphate) lipoteichoic acids. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[131] Thomas Hartung,et al. Novel Pyrogen Tests Based on the Human Fever Reaction , 2001, Alternatives to laboratory animals : ATLA.
[132] J. Marshall,et al. Cutting Edge: Distinct Toll-Like Receptor 2 Activators Selectively Induce Different Classes of Mediator Production from Human Mast Cells 12 , 2003, The Journal of Immunology.
[133] K. Yokoyama,et al. Structure and glycosylation of lipoteichoic acids in Bacillus strains , 1989, Journal of bacteriology.
[134] D. W. Kim,et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. , 2009, International immunopharmacology.
[135] A. Tomasz,et al. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid , 1985, Infection and immunity.
[136] G. Mancuso,et al. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid , 1994, Infection and immunity.
[137] P. Godowski,et al. Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses1 , 2003, The Journal of Immunology.
[138] K. Hellingwerf,et al. Isolation and characterization of lipoteichoic acid, a cell envelope component involved in preventing phage adsorption, from Lactococcus lactis subsp. cremoris SK110 , 1990, Journal of bacteriology.
[139] S. Akira,et al. Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.
[140] T. Hartung,et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[141] J. Wouters,et al. Lipoteichoic acid from Bacillus subtilis subsp. niger WM: isolation and effects on cell wall autolysis and turnover , 1987, Journal of bacteriology.
[142] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[143] M. Nagaoka,et al. Structure of macroamphiphiles from several Bifidobacterium strains , 1990, Journal of bacteriology.
[144] T. Hartung,et al. Polypropylene glycol is a selective binding inhibitor for LTA and other structurally related TLR2 agonists , 2008, European journal of immunology.
[145] T. Hartung,et al. Presentation of lipoteichoic acid potentiates its inflammatory activity. , 2008, Immunobiology.
[146] M. Rothe,et al. Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.
[147] T. Hartung,et al. A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. , 2006, Bioorganic & medicinal chemistry.
[148] S. Dower,et al. Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells1 , 2004, The Journal of Immunology.
[149] U. Göbel,et al. Lipopolysaccharide Binding Protein Binds to Triacylated and Diacylated Lipopeptides and Mediates Innate Immune Responses1 , 2004, The Journal of Immunology.